#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Nasopharyngeal cancer Infantile apnoea Congenital aplastic anaemia Philadelphia positive chronic myeloid leukaemia Anal cancer Antithrombin III deficiency Anti-myelin-associated glycoprotein associated polyneuropathy Cutaneous T-cell lymphoma Chronic graft versus host disease in skin Hypomagnesaemia Mantle cell lymphoma Prostate cancer Metastatic malignant melanoma Leukoencephalopathy Round cell liposarcoma More trials…

    Learn about Rare Diseases

    Fabry’s disease – Life with Disease Paraneoplastic neurological syndrome – Life with Disease Prolymphocytic leukaemia – Diagnostics Angiosarcoma recurrent – Diagnostics Rhabdomyosarcoma recurrent – Treatment Idiopathic inflammatory myopathy – Trials in Disease KBG syndrome – Basic Information Alternating hemiplegia of childhood – Life with Disease Rosai-Dorfman syndrome Erdheim-Chester disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ALENDRONATE SODIUM TRIHYDRATE Bintrafusp Alfa Fazirsiran Diltiazem Metformin Hydrochloride Adg126 Rp1 L-SERINE Regn7075 Famotidine Cilastatin Ivermectin CHLOROQUINE PHOSPHATE Fluorouracil Sodium Paraffin White Soft IM-101 Cetirizine Autologous Microfat Solifenacin Succinate Tofacitinib More therapies…

    Learn about Your Condition

    Haemorrhagic stroke Primary amyloidosis Burning mouth syndrome Postpartum haemorrhage Vulvovaginal discomfort Pneumonia chlamydial Irritable bowel syndrome Conjunctivitis allergic Ejection fraction normal Infective uveitis Incisional hernia Breast proliferative changes Colonoscopy Metastases to biliary tract Peripheral spondyloarthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effectiveness of Oxybutynin for Children with Overactive Neurogenic Bladder Due to Spina Bifida

    Recruiting

    3 1 1
    Investigated Diseases:
    • Spina bifida
    Investigated Drugs:
    • OXYBUTYNIN HYDROCHLORIDE
    France

  • Study on the Effectiveness of Cemiplimab, Carboplatin, and Paclitaxel for Unfit or Elderly Patients with Unresectable Stage III Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Cemiplimab
    • Carboplatin
    • Paclitaxel
    France

  • Study Comparing Lomustine Alone and Lomustine with Bevacizumab for Patients with Recurrent Glioblastoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant glioma
    Investigated Drugs:
    • Lomustine
    • Bevacizumab
    Denmark

  • Study on Reducing Vedolizumab Dosage for Patients with Inflammatory Bowel Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    • Colitis ulcerative
    Investigated Drugs:
    • Vedolizumab
    The Netherlands

  • Study on Re-treatment with Lutetium (177Lu) Vipivotide Tetraxetan for Men with Metastatic Castration-Resistant Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • Lutetium (177Lu) Vipivotide Tetraxetan
    • Gozetotide
    France

  • Study to Diagnose Cardiac Amyloidosis in Patients with Monoclonal Component Using Florbetaben (18F) PET-CT

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Florbetaben (18F)
    Italy
Previous Page
1 … 247 248 249 250 251 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!